Takeda's Partner Merges With Crestovo to Form Finch Therapeutics Group Post author:Sam Post published:October 22, 2017 Post category:BioPharma Two privately-held biotechs have merged to tackle recurrent C. difficile infections. Source: BioSpace You Might Also Like Dermira’s Acne Medication Olumacostat Glaseretil Tanks in Two Phase III Trials March 4, 2018 Novartis AG Hires Bank of America to Officially Review Alcon Options April 20, 2017 Teva, Alder BioPharma Forge $200M Anti-CGRP-Based Therapy Pact January 7, 2018
